retatrutide diabetes type 1 Retatrutide—A Game Changer in Obesity Pharmacotherapy Retatrutide and Type 1 Diabetes:

John had had a lot of difficulty in getting anybody interested in it at all, recalls Andrew Young, the former VP of research at Amylin Pharmaceuticals

Efficacy and safety of retatrutide (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial

Avoid excessively restrictive eating patterns that may compound nutritional deficits

Could lower heart risks by improving blood pressure and glucose control

Aspirin, metformin, and numerous early vaccines were developed empirically

Neuroprotective effects of GLP-1R agonism GLP-1R agonists improve cerebral blood flow (CBF): By enhancing neurovascular coupling, these drugs ensure that blood flow is properly regulated in response to brain activity, improving overall brain function, particularly in obesity and metabolic disorders